harmoni303HARMONi-3 Phase 3 Clinical Trial 1L Metastatic NSCLC NCT05899608: Click to view on A randomized, double-blind, multi-regional phase 3 Study of ivonescimabHARMONi-3 Phase 3 Clinical Trial 1L Metastatic NSCLC NCT05899608: Click to view on A randomized, double-blind, multi-regional phase 3 Study of ivonescimab